First, because it had a retrospective design and patients with threshold ROP (who underwent laser coagulation or anti-VEGF treatment) had possibly visited the hospital long enough to assess visual outcome, this study may have included a relatively small proportion of non-treated, less severe patients, therefore leading to some selection bias. The gene discussed is VEGFA; the disease is retinopathy of prematurity.